Effect of ginsenoside Rg1 on hematopoietic stem cells in treating aplastic anemia in mice via MAPK pathway

Figure 3 Impact of ginsenoside Rg1 on inflammatory cytokines in mice with aplastic anemia in the bone marrow was examined. A: Interleukin (IL)-10; B: IL-6; C: Tumor necrosis factor (TNF)-α; D: IL-1β; E: Western blot assay of IL-6, CCL2 and IL-1β in different group, the endogenous control used was GAPDH. ^bP < 0.01, compared to the control group; ^cP < 0.05, ^dP < 0.01, compared to the cyclophosphamide (CTX) group.